Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults
Public ClinicalTrials.gov record NCT02831751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Observer-Blind, Multicenter, Phase 2 Study to Assess the Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults of 65 Years of Age or Older
Study identification
- NCT ID
- NCT02831751
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Medicago
- Industry
- Enrollment
- 1,001 participants
Conditions and interventions
Conditions
Interventions
- 30 µg/strain of Quadrivalent VLP Vaccine Biological
- 60 µg/strain of Quadrivalent VLP Vaccine Biological
- FluLaval® Tetra (15 µg/strain) Biological
- Fluzone® High-Dose (60 µg/strain) Biological
Biological
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2016
- Primary completion
- Jun 30, 2016
- Completion
- Dec 31, 2016
- Last update posted
- Oct 24, 2019
2016 – 2017
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Paradigm Research - Redding | Redding | California | 96001 | — |
| Broward Research Group (BRG) | Hollywood | Florida | 33024 | — |
| Miami Research Associates (MRA) | South Miami | Florida | 33143 | — |
| Meridian Clinical Research - Savannah | Savannah | Georgia | 31406 | — |
| Meridian Clinical Research - Omaha | Omaha | Nebraska | 68134 | — |
| Regional Clinical Research (RCR) | Endwell | New York | 13760 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02831751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 24, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02831751 live on ClinicalTrials.gov.